EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.2.2.5 | nad+ glycohydrolase deficiency |
34427564 |
[Contribution and limits of CD157 in the detection of the paroxysmal nocturnal hemoglobinuria clone: a case report]. |
causal interaction unassigned |
4 0 |
3.2.2.5 | Adenocarcinoma |
8144525 |
Expression of NAD glycohydrolase activity by rat mammary adenocarcinoma cells transformed with rat T cell alloantigen RT6.2. |
causal interaction ongoing research unassigned |
3 3 0 |
3.2.2.5 | Anaphylaxis |
13773170 |
The inhibition of mast cell damage and histamine release in anaphylaxis by pyridine and diphosphopyridine nucleotidase inhibitors. Comparison with compound 48/80. |
therapeutic application unassigned |
3 0 |
3.2.2.5 | Anemia |
17852458 |
Erythrocyte CD38 as a prognostic marker in cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 4 3 1 |
3.2.2.5 | Anemia |
34427564 |
[Contribution and limits of CD157 in the detection of the paroxysmal nocturnal hemoglobinuria clone: a case report]. |
causal interaction unassigned |
4 0 |
3.2.2.5 | Anthrax |
26938870 |
NAD+-Glycohydrolase Promotes Intracellular Survival of Group A Streptococcus. |
causal interaction diagnostic usage ongoing research unassigned |
1 1 4 0 |
3.2.2.5 | Arrhythmias, Cardiac |
22526470 |
Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compounds. |
causal interaction therapeutic application unassigned |
3 4 0 |
3.2.2.5 | Arthritis, Rheumatoid |
32941246 |
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis. |
causal interaction therapeutic application unassigned |
2 1 0 |
3.2.2.5 | Bacterial Infections |
31455656 |
CD157 Confers Host Resistance to Mycobacterium tuberculosis via TLR2-CD157-PKCzeta-Induced Reactive Oxygen Species Production. |
causal interaction diagnostic usage therapeutic application unassigned |
4 3 4 0 |
3.2.2.5 | Brain Ischemia |
33304350 |
CD157 and Brain Immune System in (Patho)physiological Conditions: Focus on Brain Plasticity. |
ongoing research unassigned |
1 0 |